Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Contraception & birth control access stories

Sep 23, 2026

WHO expands contraceptive options guidelines to include emergency pills and male methods

The World Health Organization has updated its contraceptive guidelines to recommend a wider range of safe and effective options, including emergency contraception, longer-lasting implants, and future contraceptives for men. The expansion aims to give people more choices that meet their individual needs.

Sep 23, 2026·3 sources
00
Sep 16, 2026

21 Million Women Live in Counties With Limited Birth Control Access, New Maps Show

A new analysis from Power to Decide and the Guttmacher Institute maps contraception access gaps across the U.S.

Sep 16, 2026·1 source
00
Jul 29, 2026

FDA Approves Gwyn Lo, First Once-Weekly Low-Dose Estrogen Birth Control Patch

The FDA has approved Gwyn Lo (Viatris), a new contraceptive patch that delivers norelgestromin and low-dose estrogen hormones through once-weekly administration for pregnancy prevention.

Jul 29, 2026·1 source
00
Jul 10, 2026

EU Regulator Warns Desogestrel and Etonogestrel Contraceptives Carry Small Brain Tumor Risk

The European Medicines Agency safety committee announced that commonly used contraceptives containing desogestrel and etonogestrel carry a small increased risk of meningioma after prolonged use.

Jul 10, 2026·1 source
00
Apr 13, 2026

Reversible Male Contraceptive Shows Promise in Temporarily Stopping Sperm Production

Cornell scientists achieved a major breakthrough in developing a reversible male contraceptive that can temporarily halt sperm production, representing a significant advance in male birth control options.

Apr 13, 2026·2 sources
00
Apr 8, 2026

Cornell Scientists Achieve Major Breakthrough in Reversible Male Contraception

Cornell researchers have taken a significant step toward developing a safe, reversible, long-acting and 100% effective nonhormonal male contraceptive, with proof-of-concept results representing progress toward what's considered the 'holy grail' of male contraception.

Apr 8, 2026·1 source
00

Top claims

  • ▪YourChoice Therapeutics is conducting an 88-person safety trial for a nonhormonal daily male contraceptive pill.
  • ▪The World Health Organization's guide for male contraceptives outlined three development targets: inhibiting sperm production, interfering with sperm mobility, and blocking sperm passage through the ducts.
  • ▪Developers should prioritize non-hormonal male contraceptives over hormonal methods

Subtopics

Reproductive Health6Drug Approval and Clinical Trials3Drug Policy, Pricing & Approval3Longevity & biohacking2Women's reproductive health & fertility2Biohacking & optimization1Birth control access & affordability1Drug safety1European Union1Evidence based supplementation1Healthcare access1Hormone optimization1Hormone therapy1Medical innovation1Public health policy1Public healthcare1Reproductive hormones1Women’s health1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories